Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2022 Filed Mar 3, 2022 23:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Tax withholdingCommon Stock | 309 | $144.55 | $44,665.95 |
DisclosureSEC source: 0001127602-22-008106 · form4.xml · nonDerivative · entry 6 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,855 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008106 · form4.xml · nonDerivative · entry 5 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Tax withholdingCommon Stock | 367 | $144.55 | $53,049.85 |
DisclosureSEC source: 0001127602-22-008106 · form4.xml · nonDerivative · entry 4 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,114 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008106 · form4.xml · nonDerivative · entry 3 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Tax withholdingCommon Stock | 394 | $144.55 | $56,952.70 |
DisclosureSEC source: 0001127602-22-008106 · form4.xml · nonDerivative · entry 2 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,231 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008106 · form4.xml · nonDerivative · entry 1 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:11 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
GrantOptions To Purchase Common Stock · Derivative | 20,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008099 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:06 UTC |
Peterson JaclynVP of Mfg. & Adv. Engineering
|
GrantOptions To Purchase Common Stock · Derivative | 16,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008096 · form4.xml · derivative · entry 2 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2032-03-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:06 UTC |
Peterson JaclynVP of Mfg. & Adv. Engineering
|
GrantRsus (restricted Stock Units) · Derivative | 1,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008096 · form4.xml · derivative · entry 1 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:03 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
GrantOptions To Purchase Common Stock · Derivative | 35,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008095 · form4.xml · derivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:00 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
GrantOptions To Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008091 · form4.xml · derivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:51 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantRsus (restricted Stock Units) · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008087 · form4.xml · derivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2032-03-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:43 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
GrantOptions To Purchase Common Stock · Derivative | 125,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008081 · form4.xml · derivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:38 UTC |
Cohen Heather LEVP CORP HR
|
GrantOptions To Purchase Common Stock · Derivative | 33,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008076 · form4.xml · derivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:34 UTC |
Beyer PatPresident Int'l & Global Ortho
|
GrantOptions To Purchase Common Stock · Derivative | 55,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008074 · form4.xml · derivative · entry 1 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:32 UTC |
Berge Terence MVP-Corporate Controller
|
GrantOptions To Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008070 · form4.xml · derivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 8,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · derivative · entry 7 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 8,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,700 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · derivative · entry 6 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,700 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 1,582 | $149.36 | $236,281.19 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · nonDerivative · entry 5 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.04 to $149.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 6,418 | $148.36 | $952,155.23 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · nonDerivative · entry 4 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,645 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.00 to $148.93. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionCommon Stock | 8,000 | $41.93 | $335,440.00 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · nonDerivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 2,700 | $148.00 | $399,600.00 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionCommon Stock | 2,700 | $39.87 | $107,649.00 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,755 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · derivative · entry 12 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 3,755 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,245 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · derivative · entry 11 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,755 Underlying: Common Stock · 1,245 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,343 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · derivative · entry 10 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,157 Underlying: Common Stock · 3,343 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 500 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · derivative · entry 9 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,500 Underlying: Common Stock · 500 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
SaleCommon Stock | 3,755 | $149.46 | $561,206.15 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 8 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.56. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 3,755 | $97.69 | $366,825.95 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 7 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
SaleCommon Stock | 1,245 | $150.00 | $186,750.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 6 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 1,245 | $97.69 | $121,624.05 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 5 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
SaleCommon Stock | 3,343 | $149.41 | $499,481.64 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 4 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.63. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 3,343 | $78.76 | $263,294.68 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 3 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
SaleCommon Stock | 500 | $150.03 | $75,015.35 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 2 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.16. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:10 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 500 | $78.76 | $39,380.00 |
DisclosureSEC source: 0001127602-22-007313 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 21:33 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
OtherCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003389 · form5.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · daughter Disclosed balance after: 450 F1 · ownership.direct: Mr. Jonas' daughters became independent, no longer sharing the same house, during 2021, and, accordingly, Mr. Jonas no longer holds an indirect interest in shares they hold. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $55.70 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 21 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 20 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2024-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $33.43 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 19 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2023-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 18 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 17 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,549 | $0.00 Strike: $69.03 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 16 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,549 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Tax withholdingCommon Stock | 401 | $139.03 | $55,751.03 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 15 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,072 Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 1,000 | $55.70 | $55,700.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 14 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Tax withholdingCommon Stock | 286 | $139.03 | $39,762.58 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 13 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,473 Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 1,000 | $39.64 | $39,640.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 12 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Tax withholdingCommon Stock | 241 | $139.03 | $33,506.23 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 11 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,759 Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 1,000 | $33.43 | $33,430.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 10 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
SaleCommon Stock | 1,843 | $135.06 | $248,915.58 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 9 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 1,843 | $73.94 | $136,271.42 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 8 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.